Summary
- Current Price
- As of today, CCCC price is $2.54, down -10.42% on
- Current Price All-Time High
- CCCC price is currently -95.05% below its historical high of $51.21 set on
- Market Cap
- CCCC current market cap is $246M, up +186.01% over the past 365 days
- PE Ratio
- CCCC PE ratio is unknown
- Revenue
- CCCC current annual revenue is $35.95M, up +1.02% year-over-year
- Next Earnings
- The next earnings release for CCCC is on
Profile
| Metric | Value |
|---|---|
| Full Name | C4 Therapeutics, Inc. |
| Ticker | NASDAQ: CCCC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | c4therapeutics.com |
| Employees | 110 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.54 | ||
| Price, 1D Change | -10.42% | |
| $246M | ||
| - | ||
| - | ||
| 2.03 | ||
| $36M | ||
| Revenue, 1Y Change | +1.02% | |
| -$1.27 | ||
| EPS, 1Y Change | +16.57% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.27 | ||
| EPS Estimate | N/A | -$1.10 |
| EPS Est. Change | N/A | +13.41% |
| $35.95M | ||
| Revenue Estimate | N/A | $21.62M |
| Revenue Est. Change | N/A | -39.87% |
| $2.54 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +176.13% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.31 | -$1.52 | -15.76% | |
| -$1.52 | -$1.27 | +16.67% | |
| -$1.10 | N/A | +13.41% | |
| -$1.23 | N/A | +3.09% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $35.77M | $35.58M | -0.53% | |
| $30.39M | $35.95M | +18.29% | |
| $21.62M | N/A | -39.87% | |
| $21.62M | N/A | -39.87% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +109.50% | ||
| -18.75% | ||
| +186.01% | ||
| +60.53% | ||
| +1.02% | ||
| +15.60% | ||
| +16.57% | ||
| +51.72% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.54 | ||
| $2.37 | ||
| SMA 200 vs Price | -6.48% | |
| $2.49 | ||
| SMA 50 vs Price | -1.88% | |
| 2.03 | ||
| $0.25 | ||
| 46.19 | ||
| 105.88% | ||
| 104.13% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $35.95M | ||
| -$1.27 | ||
| $0.00 | ||
| 77.81% | ||
| -$104.49M | ||
| -290.68% | ||
| -$104.99M | ||
| -292.08% | ||
| -$96.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.23 | ||
| 7.81 | ||
| 7.81 | ||
| - | ||
| 5 | ||
| -0.68 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 6.83 | ||
| 0.96 | ||
| -0.59 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $256.59M | ||
| $248.54M | ||
| $371.94M | ||
| $258.11M | ||
| $115.35M | ||
| $33.03M | ||
| $59.98M | ||
| $6.37M | ||
| $858.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $140.94M | ||
| $132.46M | ||
| $7.98M | ||
| $36.20M | ||
| $8.39M | ||
| $0.00 | ||
| $121.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$98.69M | ||
| -$8.60M | ||
| $126.40M | ||
| $607.00K | ||
| -$99.30M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Brookline Capital | → | |
| Barclays | → | |
| TD Cowen | ||
| Wells Fargo | → | |
| Barclays | → | |
| Stephens & Co. | → | |
| Barclays | ||
| Stephens & Co. | → | |
| Guggenheim |
Analyst sentiment
Institutional ownership
Screeners with CCCC
FAQ
What is the ticker symbol for C4 Therapeutics, Inc.?
The ticker symbol for C4 Therapeutics, Inc. is NASDAQ:CCCC
Does C4 Therapeutics, Inc. pay dividends?
No, C4 Therapeutics, Inc. does not pay dividends
What sector is C4 Therapeutics, Inc. in?
C4 Therapeutics, Inc. is in the Healthcare sector
What industry is C4 Therapeutics, Inc. in?
C4 Therapeutics, Inc. is in the Biotechnology industry
What country is C4 Therapeutics, Inc. based in?
C4 Therapeutics, Inc. is headquartered in United States
When did C4 Therapeutics, Inc. go public?
C4 Therapeutics, Inc. initial public offering (IPO) was on October 2, 2020
Is C4 Therapeutics, Inc. in the S&P 500?
No, C4 Therapeutics, Inc. is not included in the S&P 500 index
Is C4 Therapeutics, Inc. in the NASDAQ 100?
No, C4 Therapeutics, Inc. is not included in the NASDAQ 100 index
Is C4 Therapeutics, Inc. in the Dow Jones?
No, C4 Therapeutics, Inc. is not included in the Dow Jones index
When was C4 Therapeutics, Inc. last earnings report?
C4 Therapeutics, Inc.'s most recent earnings report was on February 26, 2026
When does C4 Therapeutics, Inc. report earnings?
The next expected earnings date for C4 Therapeutics, Inc. is May 7, 2026
Data Sources & References
- CCCC Official Website www.c4therapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1662579/000162828026012000/0001628280-26-012000-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1662579/000162828026012000/0001628280-26-012000-index.htm
- CCCC Profile on Yahoo Finance finance.yahoo.com/quote/CCCC
- CCCC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cccc